Press room
New curriculum raises kidney awareness
Open access journal comes to SAGE Publishing with six-part series on kidney care and treatment
A new series on core curriculum for kidney specialists has been released by the Canadian Journal of Kidney Health and Disease, the official journal of the Canadian Society of Nephrology. Covering the diverse nature of kidney health research and clinical practice, the open access journal is now published by SAGE Publishing.
The six-part series covers various treatments for kidney failure and how kidney doctors can make treatment decisions based on patient evaluations. It also discusses managing these treatments and their related potential complications.
“The series has been developed by experts to address the practical aspects of vascular access ranging from the selection of an appropriate access, the management of complications and issues relevant to the daily care of an access,” commented series author Jennifer MacRae. “Nephrologists, students, and educators will be able to use this curriculum as a resource since each topic has been designed to encompass the key relevant literature along with pertinent links to external resources and a summary section highlighting the main educational points.”
The series is published alongside the journal’s other articles on clinical, translational and health services delivery research in the field of chronic kidney disease, dialysis, kidney transplantation, and organ donation. Dedicated to promoting and advocating for global kidney health, the Canadian Journal of Kidney Health and Disease transitioned to SAGE Publishing to enhance author services and the global visibility of its kidney health research.
“This move brings with it lower overall fees, further reduced rates for CSN members, and improvements in software, support and services for authors, reviewers and editors, “ commented Editor-in-Chief Adeera Levin, M.D. “We anticipate that a more robust platform and the engaged and experienced staff at SAGE Publishing will help us to further our mandate of supportive review, minimize the rounds of feedback between journal and authors, and improve the quality of the final manuscript while also enhancing the quality and ease of the peer-review process itself.”
“Partnering with the Canadian Society of Nephrology, our goal is to amplify the readership of its official journal and to accelerate the publication of its key research findings,” commented Bob Howard, Vice President of Journals, SAGE Publishing. “The Canadian Journal of Kidney Health and Disease makes a strong addition to our open access portfolio and we are delighted to enhance its impact.”
The journal accepts original research, translational studies and clinical studies. Its editorial board consists of geographically diverse Canadian and international nephrologists, internists and allied health professionals. For more information, please click hereCanadian Journal of Kidney Health and Disease.
# # #
The six articles in this series include:
|
“Arteriovenous vascular access selection and evaluation”
|
When making decisions regarding vascular access creation, the clinician and vascular access team must evaluate each patient individually with consideration of life expectancy, timelines for dialysis start, risks and benefits of access creation, referral wait times as well as the risk for access complications. The role of the multidisciplinary team in facilitating access choice is reviewed as well as the clinical evaluation of the patient. (MacRae et al)
|
|
Vascular access related complications can lead to patient morbidity and reduced patient quality of life. Some of the common arteriovenous access complications include failure to mature, stenosis formation and thrombosis. (MacRae et al) |
|
|
|
|
|
“Arteriovenous access: infection, neuropathy and other complications” |
Complications of vascular access lead to morbidity and may reduce quality of life. In this module we review both infectious and non-infectious arteriovenous access complications including neuropathy, aneurysm and high-output access. For the challenging patients who have developed many complications and are now nearing their last vascular access we highlight some potentially novel approaches. (MacRae et al) |
|
“Practical aspects of nontunneled and tunneled hemodialysis catheters” |
Non-tunneled hemodialysis catheters (NTHCs) are typically used when vascular access is required for urgent renal replacement therapy. The preferred site for NTHC insertion in acute kidney injury is the right internal jugular vein followed by the femoral vein. When aided by real-time ultrasound, mechanical complications related to NTHC insertion are significantly reduced. The preferred site for tunneled hemodialysis catheters placement is the right internal jugular followed by the left internal jugular vein. Ideally, the catheter should be inserted on the opposite side of a maturing or planned fistula/ graft. Several dual lumen, large diameter catheters are available with multiple catheter tip designs, but no one catheter has shown significant superior performance. (Clark et al) |
|
Catheter-related bloodstream infections, exit-site infections and tunnel infections are common complications related to hemodialysis central venous catheter use. The various definitions of catheter related infections are reviewed and various preventative strategies are discussed. Treatment options, for both empiric and definitive infections, including antibiotic locks and systemic antibiotics are reviewed. (Miller et al) |
|
|
“Hemodialysis tunneled catheter noninfectious complications” |
Non-infectious hemodialysis catheter complications include catheter dysfunction, catheter-related thrombus and central vein stenosis. The definitions, causes and treatment strategies for catheter dysfunction are reviewed below. Catheter-related thrombus is a less common, but serious complication of catheters, requiring catheter removal and systemic anticoagulation. In addition, the risk factors, clinical manifestation and treatment options for central vein stenosis are outlined. (Miller et al) |
# # #
Sara Miller McCune founded SAGE Publishing in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE is a leading international provider of innovative, high-quality content publishing more than 900 journals and over 800 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. www.sagepublishing.com
The Canadian Society of Nephrology is a society of physicians and scientists specializing in the care of people with kidney disease, and in research related to the kidney and kidney disease. www.csnscn.ca
Contact (media inquiries only)
- Louise Coady, Head of Corporate Communications and Public Affairs: louise.coady@sagepub.co.uk / Tel: (+44) (0)7810 807291
- Camille Gamboa, Director of Corporate Communications and Public Affairs: camille.gamboa@sagepub.com / Tel: (+1) 805-410-7441